Good to see. However, I don't see much excitement in AGRX for the rest of the year - in fact it might offer some buying opportunities on softness. With FDA now scheduled for mid February, perhaps we'll start to see some buzz mid January or a little later.
If I could afford to buy all of them, I would not need to buy any of them and I sure wouldn't be spending time on the message boards!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.